← Back to headlines
Jefferies Upgrades French Biotech Stock to Buy Following New Drug Data
Analyst Faisal Khurshid at Jefferies has upgraded a French biotech stock from hold to buy, citing promising new drug data as the reason for the positive outlook.
1 Jul, 10:12 — 1 Jul, 10:12
Sources
Showing 1 of 1 sources
